Immunotherapy for Treatment of Pleural Mesothelioma: Current and Emerging Therapeutic Strategies
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Pleural mesothelioma, a rare cancer linked to asbestos, has poor survival rates. Recent immunotherapy advancements show promise, with ongoing trials exploring new strategies to improve patient outcomes.
Area Of Science
- Oncology
- Immunology
Background
- Pleural mesothelioma is a rare cancer with a poor prognosis, often linked to asbestos exposure.
- Survival rates are low, with a 5-year overall survival of approximately 12%.
- Prognosis is influenced by disease stage and histologic subtype.
Purpose Of The Study
- To review the implementation of immunotherapy in clinical practice for pleural mesothelioma.
- To highlight ongoing clinical trials investigating novel immunotherapy strategies.
- To discuss challenges and future directions for immunotherapy in mesothelioma treatment.
Main Methods
- Review of clinical trials and studies on immunotherapy for pleural mesothelioma.
- Analysis of current treatment regimens, including dual checkpoint inhibitors and chemotherapy combinations.
- Examination of ongoing research and future therapeutic strategies.
Main Results
- Immunotherapy, particularly dual checkpoint inhibitors combined with chemotherapy, has shown impactful changes in patient outcomes.
- Successful implementation of immunotherapy in clinical practice has been demonstrated.
- Ongoing trials are exploring various immunotherapy approaches.
Conclusions
- Immunotherapy represents a significant advancement in treating pleural mesothelioma.
- Further research is crucial to overcome existing challenges and optimize immunotherapy efficacy.
- Future strategies aim to enhance treatment outcomes for patients with this rare malignancy.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
Visceral Pleura: This layer covers the lungs.
Parietal Pleura: This layer lines the inside of the chest wall.
Between the two layers — the visceral pleura lining the lungs and the parietal pleura lining the chest cavity — lies the pleural cavity, a crucial anatomical space. This cavity houses a thin layer of...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...